Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          Enter the terms you wish to search for.
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations Breadcrumb
    Home
                              About
                              News
                              Readout of HHS Secretary Becerra’s Meeting with Pharmacies, Pharmacy Benefit Managers, and Insurers on COVID-19 Therapeutics Commercialization
 Navigate to:
  News
    
                                    
                                            
            
      
      
      
      Blog
    
                                    
                                            
            
      
      
      
      HHS Live
    
                                    
                                            
            
      
      
      
      Podcasts
    
                                    
                                            
            
      
      
      
      Media Guidelines for HHS EmployeesText resize icon

                    




**FOR IMMEDIATE RELEASE January 9, 2024**

        **Contact:
            HHS Press Office 
              202-690-6343media@hhs.gov**

          Readout of HHS Secretary Becerra’s Meeting with Pharmacies, Pharmacy Benefit Managers, and Insurers on COVID-19 Therapeutics Commercialization
    
    

      *Secretary Becerra highlighted the importance of access to COVID-19 therapeutics and reiterated HHS’ commitment to partnering with pharmacies and insurers to better serve the American people.*

On Tuesday, January 9, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra met virtually with pharmacy leaders, pharmacy benefit managers, and insurers to discuss HHS’ continued commitment and partnership to increase equitable access to COVID-19 therapeutics.

During the call, Secretary Becerra reminded participants that no patient should be forced to pay the full out-of-pocket cost to access Paxlovid and asked that stakeholders immediately alert HHS of any issues that arise regarding COVID-19 therapeutics access. Secretary Becerra reiterated HHS’ commitment to ensuring smooth access to oral antivirals for COVID-19 and encouraged all providers to ensure patients who experience issues accessing Paxlovid or Lagevrio are directed to the designated patient assistance programs available for both antivirals. Finally, he highlighted the importance of continued provider ordering of commercially available oral antivirals and provider education.

The Biden-Harris Administration has made historic progress in our nation’s ability to manage COVID-19 so that it no longer meaningfully disrupts the way we live our lives. For the first time, vaccines are available to protect older adults in the United States against all three winter respiratory illnesses – COVID-19, flu, and RSV – and there are millions of courses of free USG Paxlovid at provider sites across the country available by the federal government. Free COVID-19 tests are also available at COVIDTest.gov.

Today’s call is part of a series of recent actions HHS has taken to maintain broad access to oral antivirals for COVID-19 as part of the transition to the commercial market:

Since last fall, HHS, the Administration for Strategic Preparedness & Response (ASPR), the Centers for Medicare & Medicaid Services (CMS), and Pfizer have regularly met with stakeholder groups to discuss increased Paxlovid access and address other stakeholder questions around oral antivirals commercialization.
	As of October 13, 2023, HHS and Pfizer reached an agreement extending patient access to Paxlovid, maximizing taxpayer investment, and beginning Paxlovid’s transition to the commercial market. Under the October 2023 agreement, individuals - including those on Medicare and Medicaid - maintain access to Paxlovid through the end of 2024. The agreement also enables access for the uninsured through 2028, ensures that no HHS-procured product will be lost to expiry, and has ensured that Pfizer will create a stockpile for future emergencies.
	On October 27, 2023, at the outset of Paxlovid’s transition to the commercial market, Secretary Becerra wrote to therapeutics manufacturers, distributors, pharmacies, and the health care payer community requesting their partnership as therapeutics transitioned to the commercial market and asking that they inform HHS immediately if they encounter any operational problems that impede patient access to these treatments.
	On January 4, 2024, CMS released guidance for Medicare Part D plans that describes coverage and processing claims for COVID-19 therapeutics. As a reminder, Medicare Part D plans must cover commercially available oral antivirals for COVID-19, either as a formulary product or through the formulary exception process.  We expect that many Part D plans will take advantage of an agreement with Pfizer that will allow their enrollees to access Paxlovid for free through the plan without needing to enroll in Pfizer’s patient assistance program.
  

    ###
    Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.Like HHS on Facebook, follow HHS on Twitter @HHSgov, and sign up for HHS Email Updates.Last revised: January 9, 2024

  
  
  







  Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases

Sign Up







  Subscribe to RSS
    

      Receive latest updates







  Related News Releases
    

      HHS, DHS, and FEMA Announce Completion of Multi-Year Review of State Efforts to Provide Language Access During the COVID-19 Public Health Emergency
  

Readout of HHS Secretary Becerra’s Meeting with Pharmacy CEOs on COVID-19 Therapeutics Commercialization
  

Readout of HHS Meeting with Health Care Providers on COVID-19 Therapeutics Commercialization







  Related Blog Posts
    

      Calling innovators! HHS Long COVID Healthathon launches with $25K in prizes
  

Reflections from the Deputy Director of the HHS Office of Long COVID Research and Practice
  

Driving Long COVID Innovation with Health+ Human-Centered Design

                    
  


Media Inquiries

For general media inquiries, please contact media@hhs.gov.







  Content created by Assistant Secretary for Public Affairs (ASPA) Content last reviewed January 9, 2024 Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility Statement
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​